What is the price target for LUCD stock?
11 analysts have analysed LUCD and the average price target is 4.03 USD. This implies a price increase of 259.73% is expected in the next year compared to the current price of 1.12.
NASDAQ:LUCD • US54948X1090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LUCID DIAGNOSTICS INC (LUCD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-30 | BTIG | Reiterate | Buy -> Buy |
| 2026-03-26 | Needham | Reiterate | Buy -> Buy |
| 2025-12-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-11-13 | Needham | Reiterate | Buy -> Buy |
| 2025-10-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-10 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-05 | BTIG | Maintains | Buy -> Buy |
| 2025-08-13 | Needham | Reiterate | Buy -> Buy |
| 2025-07-16 | Needham | Reiterate | Buy -> Buy |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-05-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-14 | Needham | Reiterate | Buy -> Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-11 | Needham | Reiterate | Buy -> Buy |
| 2025-03-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-24 | Needham | Maintains | Buy -> Buy |
| 2024-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-15 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-11-14 | Needham | Reiterate | Buy -> Buy |
| 2024-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-05-15 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.428M 538.95% | 4.346M 79.00% | 4.706M 8.28% | 10.642M 126.14% | 25.41M 138.77% | 29.274M 15.21% | 77.21M 163.75% | 113.72M 47.29% | |
| EBITDA YoY % growth | -45.983M 15.21% | -44.885M 2.39% | -48.768M -8.65% | -39.372M 19.27% | -36.771M 6.61% | -42.33M -15.12% | -34.68M 18.07% | -23.46M 32.35% | |
| EBIT YoY % growth | -48.482M 13.69% | -46.052M 5.01% | -49.64M -7.79% | -44.233M 10.89% | -36.633M 17.18% | -27.714M 24.34% | -17.71M 36.10% | -5.221M 70.52% | |
| Operating Margin | -1,996.79% | -1,059.64% | -1,054.82% | -415.64% | -144.17% | -94.67% | -22.94% | -4.59% | |
| EPS YoY % growth | -1.22 11.59% | -1.06 13.11% | -0.80 24.53% | -0.35 56.55% | -0.22 37.21% | -0.31 -40.19% | -0.26 16.67% | -0.18 28.00% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 83.72% | -0.07 6.93% | -0.07 32.68% | -0.06 40.16% | -0.08 7.83% | -0.06 14.38% | -0.06 16.67% | -0.04 31.82% |
| Revenue Q2Q % growth | 1.406M 69.81% | 1.891M 62.60% | 3.219M 165.81% | 4.125M 174.27% | 7.344M 422.33% | 8.976M 374.67% | 11.424M 254.89% | 13.056M 216.51% |
| EBITDA Q2Q % growth | -11.679M 4.79% | -11.526M -5.35% | -11.067M 0.26% | -10.659M 18.88% | -8.16M 30.13% | -7.344M 36.28% | -6.222M 43.78% | -4.896M 54.07% |
| EBIT Q2Q % growth | -13.01M -4.19% | -12.829M -12.69% | -12.416M -5.59% | -12.03M 14.14% | -8.67M 33.36% | -7.548M 41.16% | -6.12M 50.71% | -4.488M 62.69% |
All data in USD
11 analysts have analysed LUCD and the average price target is 4.03 USD. This implies a price increase of 259.73% is expected in the next year compared to the current price of 1.12.
LUCID DIAGNOSTICS INC (LUCD) will report earnings on 2026-05-12, before the market open.
The consensus EPS estimate for the next earnings of LUCID DIAGNOSTICS INC (LUCD) is -0.08 USD and the consensus revenue estimate is 1.41M USD.
The expected long term growth rate for LUCID DIAGNOSTICS INC (LUCD) is 84.62%.